亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Tumor size and molecular risk group are associated with differentiated thyroid cancer recurrence

医学 甲状腺癌 肿瘤科 内科学 甲状腺
作者
Saba Kurtom,Jason B. Liu,William R Doerfler,Michael J. Calcaterra,Kelly L. McCoy,Alaa Sada,Kimberly M. Ramonell,Sally E. Carty,Marina N. Nikiforova,Yuri E. Nikiforov,Linwah Yip
出处
期刊:Surgery [Elsevier BV]
卷期号:177: 108838-108838 被引量:14
标识
DOI:10.1016/j.surg.2024.06.066
摘要

BACKGROUND: The threshold at which active surveillance can be considered is variable, with some algorithms proposing nonoperative treatment for differentiated thyroid carcinomas ≤2 cm and lobectomy alone for lesions 2.1-4 cm. To inform both decision for and extent of initial surgery, we aim to evaluate whether molecular results can complement tumor size to identify differentiated thyroid carcinomas associated with disease recurrence. METHODS: Patients from 2007-2013 and 2017-2021 who had initial thyroidectomy (differentiated thyroid carcinoma size 1-4 cm, clinical N0M0) were included. When available, molecular testing results were categorized into 3 previously described molecular risk groups (low, intermediate, and high). Primary outcome was structural recurrence. RESULTS: Recurrence was diagnosed in 3.8% of 1,739 patients with differentiated thyroid carcinomas. Preoperative variables including size (1-2 cm vs 2.1-4 cm, P = .43), age >55 years (P = .92), and male sex (P = .31) were not associated with recurrence. Molecular testing results were available for 1,020, and after excluding molecular risk group high-risk differentiated thyroid carcinoma, structural recurrences were associated with molecular risk group intermediate risk (7.2% vs molecular risk group low, 0.7%, P < .001), and most likely in differentiated thyroid carcinoma, which were both 2.1-4 cm and molecular risk group intermediate risk (11.3% vs size 1-2 cm 5.8%, P = .04). CONCLUSION: Overall, structural recurrences for differentiated thyroid carcinomas ≤4 cm were low (<5%) and molecuar testing was the only preoperative variable associated with recurrence. However, when molecular risk group intermediate risk was present, larger tumor size (2.1-4 cm) had a 2-fold greater risk of recurrence compared with tumors 1-2 cm, and size may still be helpful to guide management. When considering de-escalated treatment for the proposed guidelines with a cutoff of 2 cm, initial decision-making may be further optimized with identification of preoperative molecular risk groups.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
研猫发布了新的文献求助10
刚刚
1秒前
英俊鼠标完成签到 ,获得积分10
4秒前
科研兄发布了新的文献求助10
4秒前
5秒前
刘甜甜完成签到,获得积分10
6秒前
南西完成签到,获得积分10
8秒前
羟基苯甲醛关注了科研通微信公众号
8秒前
无情的踏歌完成签到,获得积分0
9秒前
阳光采蓝完成签到,获得积分10
9秒前
h11的应助被科研兄采纳,获得10
11秒前
海绵宝宝完成签到 ,获得积分10
11秒前
GingerF的应助被科研通管家采纳,获得10
12秒前
null的应助被科研通管家采纳,获得10
13秒前
学霸业的应助被科研通管家采纳,获得50
13秒前
13秒前
研猫发布了新的文献求助10
13秒前
丘比特的应助被无情的踏歌采纳,获得10
14秒前
山与完成签到 ,获得积分10
14秒前
19秒前
乐乐的应助被无情的踏歌采纳,获得10
23秒前
23秒前
24秒前
怡然冰颜完成签到 ,获得积分10
25秒前
26秒前
古月发布了新的文献求助10
29秒前
谎1028完成签到 ,获得积分10
29秒前
Nikkie2411的应助被闪闪婴采纳,获得10
35秒前
Criminology34的应助被无情的踏歌采纳,获得30
35秒前
jinjinjin完成签到 ,获得积分10
37秒前
kskbl完成签到 ,获得积分10
38秒前
科研通AI6.2的应助被哈哈采纳,获得10
38秒前
urologywang完成签到 ,获得积分10
39秒前
40秒前
h11的应助被Coral369采纳,获得10
41秒前
李程辉完成签到 ,获得积分10
43秒前
靳南希完成签到 ,获得积分10
43秒前
45秒前
优美的烙完成签到,获得积分10
45秒前
研猫发布了新的文献求助10
45秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158533
求助须知:如何正确求助?哪些是违规求助? 9554315
关于积分的说明 21718840
捐赠科研通 7747967
什么是DOI,文献DOI怎么找? 3427015
关于科研通互助平台的介绍 2551811
邀请新用户注册赠送积分活动 2471239